Table 1.
Studies, year | Studies characteristics | ||||||||
Location | Design | Sample size | Population/Sample | Index Test |
Index Test Gene Target |
Reference Test | Ref. Test Gene Target | Clinical settings | |
16 | Calgary, Canada | Cross- sectional |
124 | COVID-19 patients/Archived nasopharyngeal swab | Warmstart RT-LAMP assay | S and RdRP gene | RT-PCR | E gene and N2 gene | N/A |
13 | Penzberg, Germany | Cross-sectional | 137 | COVID-19 patients/Archived nasopharyngeal swab | Variplex RT-LAMP assay | [M] gene | LightMix E-Gene RT-PCR* | E gene | N/A |
8 | Hongkong | Cross-sectional | 362 | COVID-19 and other viral infection/Nasopharyngeal swab | COVID-19 RT-LAMP assay | orf3a and E gene | qRT-PCR | N/A | Inpatient |
14 | Saitama, Japan | Cross-sectional | 76 | Suspected COVID-19 patient/N/A | Loopamp SARS-COV-2 Detection Kit | N/A | qRT-PCR | N gene | Outpatient |
1 | Guangdong, China | Cohort | 481 | Suspected COVID-19 patient/N/A | RT-LAMP Kit | S gene | ABI COVID-19 qRT-PCR Kit* | ORF1ab geneN genes | Inpatient |
18 | Wenzhou, China | Cross-sectional | 260 | COVID-19 and other viral infection/Nasopharyngeal swab | RT-LAMP Kit | N gene | NPMA qRT-PCR | orf1ab gene, N gene | N/A |
6 | Beijing, China | Cross-sectional | 130 | COVID-19 and pneumonia patients/|Nasopharyngeal swab | Loopamp RNA amplification kit [RT-LAMP] | orf1ab gene; S gene | BGI RT-PCR Kit* | orf1ab and S genes | N/A |
4 | Belmont, USA | Cross-sectional | 20 | N/A/Serum, urine, oropharyngeal,nasopharyngeal swab | RT-LAMP Kit | NSP 3 gene; ORF1Ab gene | qRT-PCR | N1 and N2 gene | Outpatient |
5 | Nantong, China | Cross-sectional | 56 | Suspected COVID-19 patients/Nasopharyngeal swab | Warmstart RT-LAMP Assay | N gene | RT-qPCR kit | N/A | Inpatient |
7 | Seoul, South Korea | Cross-sectional | 154 | COVID-19 and other viral infection/Nasopharyngeal swab | Warmstart RT-LAMP Assay | N gene | Bio-rad iTaq Universal Probes One-Step Kit qRT-PCR*** | N/A | N/A |
17 | Melbourne, Australia | Cross-sectional | 157 | N/A/Nasopharyngeal swabs | RT-LAMP Mastermix | N gene | Quantabio qScript XLT One-Step RT-qPCR ToughMix** | E gene | N/A |
12 | Heidelberg, Germany | Cross-sectional | 77 | Random eligible sample/Nasopharyngeal swab | Colorimetric and Fluorescence RT-LAMP | N gene | LightCycler® Multiplex RNAVirus Master kit*** | E gene | N/A |
15 | Sungai Buloh, Malaysia | Cross-sectional | 89 | COVID-19 patients/Archived nasopharyngeal swab | RT-LAMP Kit | RdRP and E genes | Invitrogen Superscript III one step RT-PCR system* | RdRP and E genes | N/A |
9 | Ningbo, China | Cross-sectional | 16 | COVID-19 and other viral infection/Nasopharyngeal swab | RT-LAMP Kit | orf1ab, N, and E gene | Shanghai ZJ Bio- Tech 2019-nCoV RT-PCR kit* | orf1ab, S, and N gene | Outpatient |
Legend: E (envelope]; N (nucleocapsid), S (spike protein); M (membrane protein); ORF1ab (Open Reading Frame 1ab); RdRP (RNA dependent RNA polymerase gene); NSP3 (nonstructural protein 3)
Notes:
*Approved reference method by WHO
**Approved reference method by CDC*** Approved reference method by FDA